Breast cancer resistance mechanisms: challenges to immunotherapy.
Ann HannaJustin M BalkoPublished in: Breast cancer research and treatment (2021)
The breast cancer immune TME is complex and the mechanisms driving resistance to ICB are multifaceted. Continued study in both preclinical models and clinical trials should help elucidate these mechanisms so they can be targeted to benefit more breast cancer patients.